Skip to main content

Table 3 Cell cycle regulators are more affected by MT19C at earlier times while translation regulators and ribosomes are affected at later times by GSEA.

From: Integrated genomics of ovarian xenograft tumor progression and chemotherapy response

Geneset

NES

P-value

FDR

Treat8 vs. Naive8

   

Biocarta (n = 184)

   

ATRBRCA pathway

1.74

0.000

0.315

MTA3 pathway

-1.87

0.000

0.141

GenMapp (n = 107)

   

DNA Replication

1.84

0.000

0.024

G1 to S Cell Cycle Reactome

1.59

0.006

0.122

Krebs TCA Cycle

1.49

0.033

0.219

Galactose metabolism

-1.88

0.000

0.113

Oxidative Phosphorylation

-1.68

0.002

0.139

Nuclear Receptors

-1.59

0.013

0.227

Kegg (n = 165)

   

Cell Cycle

1.94

0.000

0.013

Transcription factor targets (n = 614)

   

E2F1s

1.76-2.05

0.000

0.000-0.008

Bach2

-1.73

0.000

0.037

Treat16 vs. Naive16

   

Genmapp (n = 107)

   

Ribosomal proteins

2.41

0.000

0.000

Aminoacyl tRNA biosynthesis

2.05

0.002

0.003

Translation Factors

1.66

0.005

0.203

  1. Comparisons are indicated byTreat8 vs. Naive8 and Treat16 vs. Naive 16. NES > 0 indicates higher expression in MT19C treated tumors and NES < 0 indicates higher expression in naïve tumors.